Long Wake/Short Sleep Bouts and Hyperactivity with Advanced Age in a Mouse Model of Early Onset Alzheimer’s Disease
Preprint
- 16 June 2026
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
Abstract
Poor sleep quality and reduced sleep duration are associated with Alzheimer’s disease (AD)-related β-amyloid (Aβ) pathologies. We conducted two studies of sleep/wake, activity and body temperature in AppNL-G-F mice, a strain that exhibits three mutations in the human App gene associated with elevated risk for early onset AD. First, AppNL-G-F mice were compared to wildtype (WT) littermates at 14-18 and 18-22 months of age and, at both ages, were found to exhibit more Wake and less NREM and REM sleep than WT littermates. This long wake/short sleep phenotype was evident during the dark phase at 14-18 months but occurred in both the light and dark phases at 18-22 months. AppNL-G-F mice had fewer short (260 sec) Wake bouts and were hyperactive at 18-22 months, which undoubtedly contributed to the increased Wake/reduced sleep. Despite this reduced sleep phenotype, AppNL-G-F mice were no sleepier than WT mice and the sleep homeostat was functional in both strains. In the second study, sex differences in these parameters were assessed at 18-24 months. Reduced sleep was evident in both sexes of AppNL-G-F mice but was clearly more evident in females. Wake and REM sleep bout durations were longer in both sexes of AppNL-G-F mice than in WT littermates. EEG spectral power during NREM sleep was reduced in female AppNL-G-F mice between 4.88-10.50 Hz compared to WT mice whereas, during REM sleep, both male and female AppNL-G-F mice exhibited reduced spectral power in the theta range. These results suggest that Aβ deposition may impair state transition mechanism(s) in AppNL-G-F mice and demonstrate that, as in human AD patients, the long wake/short sleep phenotype was more evident in female AppNL-G-F mice, thus supporting the use of this strain as a model to investigate interventions that mitigate AD burden during early disease stages.Keywords
All Related Versions
This publication has 68 references indexed in Scilit:
- Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Sex differences in dementia risk and risk factors: Individual‐participant data analysis using 21 cohorts across six continents from the COSMIC consortiumAlzheimer's & Dementia, 2023
- Targeting Sleep and Circadian Function in the Prevention of Alzheimer DiseaseJAMA Neurology, 2022
- Altered sleep and EEG power in the P301S Tau transgenic mouse modelAnnals of Clinical and Translational Neurology, 2017
- Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s diseaseActa Neuropathologica, 2016
- Tau positron emission tomographic imaging in aging and early Alzheimer diseaseAnnals of Neurology, 2015
- Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaJAMA, 2015
- Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer DiseaseJAMA Neurology, 2014
- Sex Differences in the Clinical Manifestations of Alzheimer Disease PathologyArchives of General Psychiatry, 2005
- Sex and the Risk of Restless Legs Syndrome in the General PopulationArchives of internal medicine (1960), 2004